Or planning to break itself up?
AstraZeneca is discussing a potential sale of large parts of its early research into gastrointestinal diseases, a Swedish newspaper reported, citing unidentified sources.
The Anglo-Swedish drug maker was discussing a possible divestment of initially four to five research projects with venture capital firms as well as companies in the drug industry, Swedish business daily Dagens Industri reported.
More at Reuters
No comments:
Post a Comment